本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Trevi Therapeutics Inc.

15.13
+0.11500.77%
成交量:61.87萬
成交額:950.97萬
市值:21.48億
市盈率:-42.99
高:15.57
開:15.38
低:15.11
收:15.01
52周最高:20.22
52周最低:7.97
股本:1.42億
流通股本:1.18億
量比:0.66
換手率:0.52%
股息:- -
股息率:- -
每股收益(TTM):-0.3518
每股收益(LYR):-0.3173
淨資產收益率:-19.66%
總資產收益率:-13.82%
市淨率:6.68
市盈率(LYR):-47.66

資料載入中...

2022/05/16

重要事件披露

8-K - Current report
2022/05/12

重要事件披露

8-K - Current report
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/09

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/04/25

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/21

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/07

重要事件披露

8-K - Current report
2022/03/17

重要事件披露

8-K - Current report
2022/03/17

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

重要事件披露

8-K - Current report
2022/03/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/24

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/01

重要事件披露

8-K - Current report